BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23935945)

  • 1. Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancer.
    Huang CY; Zhao JJ; Lv L; Chen YB; Li YF; Jiang SS; Wang W; Pan K; Zheng Y; Zhao BW; Wang DD; Chen YM; Yang L; Zhou ZW; Xia JC
    PLoS One; 2013; 8(7):e69155. PubMed ID: 23935945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis.
    Huang CY; Chen YM; Zhao JJ; Chen YB; Jiang SS; Yan SM; Zhao BW; Pan K; Wang DD; Lv L; Li YF; Wang W; Zhou ZW; Xia JC
    PLoS One; 2013; 8(1):e54671. PubMed ID: 23372750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
    Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
    PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis.
    Wang W; Lv L; Pan K; Zhang Y; Zhao JJ; Chen JG; Chen YB; Li YQ; Wang QJ; He J; Chen SP; Zhou ZW; Xia JC
    PLoS One; 2011; 6(9):e24897. PubMed ID: 21966377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma.
    Keshari RP; Wang W; Zhang Y; Wang DD; Li YF; Yuan SQ; Qiu HB; Huang CY; Chen YM; Xia JC; Zhou ZW
    PLoS One; 2014; 9(2):e87195. PubMed ID: 24504018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
    Albertus DL; Seder CW; Chen G; Wang X; Hartojo W; Lin L; Silvers A; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Bigbee WL; Chinnaiyan AM; Beer DG
    J Thorac Oncol; 2008 Nov; 3(11):1236-44. PubMed ID: 18978557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
    Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
    Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis.
    Huang Y; Li LZ; Zhang CZ; Yi C; Liu LL; Zhou X; Xie GB; Cai MY; Li Y; Yun JP
    J Transl Med; 2012 May; 10():106. PubMed ID: 22625427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients.
    Yang XB; Zhao JJ; Huang CY; Wang QJ; Pan K; Wang DD; Pan QZ; Jiang SS; Lv L; Gao X; Chen HW; Yao JY; Zhi M; Xia JC
    PLoS One; 2013; 8(10):e78158. PubMed ID: 24194912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients.
    Zheng Y; Wang DD; Wang W; Pan K; Huang CY; Li YF; Wang QJ; Yuan SQ; Jiang SS; Qiu HB; Chen YM; Zhang XF; Zhao BW; Mai C; Xia JC; Zhou ZW
    PLoS One; 2014; 9(4):e93073. PubMed ID: 24698999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor prognosis of gastric adenocarcinoma with decreased expression of AHRR.
    Li YF; Wang DD; Zhao BW; Wang W; Yuan SQ; Huang CY; Chen YM; Zheng Y; Keshari RP; Xia JC; Zhou ZW
    PLoS One; 2012; 7(8):e43555. PubMed ID: 22952704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level of COP1 expression is associated with poor prognosis in primary gastric cancer.
    Li YF; Wang DD; Zhao BW; Wang W; Huang CY; Chen YM; Zheng Y; Keshari RP; Xia JC; Zhou ZW
    Int J Biol Sci; 2012; 8(8):1168-77. PubMed ID: 23091414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer.
    Zhang AY; Grogan JS; Mahon KL; Rasiah K; Sved P; Eisinger DR; Boulas J; Vasilaris A; Henshall SM; Stricker PD; Kench JG; Horvath LG
    Ann Oncol; 2017 Aug; 28(8):1903-1909. PubMed ID: 28486686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognosis of MYOZ2 in gastric cancer.
    Li YF; Zhu GY; Ma Y; Qu HY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.